I hope this message finds you well. My name is Emilio Amador, and I am writing you from VOZ Advisors, a patient engagement and advocacy relations firm specializing in helping pharmaceutical and biotech companies bring patient perspectives into the drug development process.
We are currently working with a global pharmaceutical company investigating a potential treatment for the negative and cognitive symptoms associated with schizophrenia. To deepen its understanding of the impact of negative and cognitive symptoms, on people living with schizophrenia and their care partners, the company is planning an advisory board meeting with care partners and professional caregivers this March. VOZ is supporting the company in identifying care partners who are interested in sharing their perspectives during the meeting.
Given your connection to the schizophrenia community, I’d love to learn more about your perspective and share some information about our project. Below I am including my email address. I’d also be happy to send additional information about the meeting. My email is [firstname.lastname@example.org]
I’ve included a bit of information about VOZ Advisors below, for your background. Please feel free to reach out with any questions you may have.
Looking forward to hearing from you,
VOZ Advisors has been working with stakeholders and patient advocacy organizations for over 20 years to integrate their perspectives and voice throughout the drug development continuum for biotech and pharmaceutical companies. We’ve worked in a broad range of therapeutic areas including cardiovascular disease, hematology, infectious disease, chronic disease, oncology, and rare disease. Should you be interested in reading about our current clients and case studies, please visit our website: www.VOZAdvisors.com